References
- van Leeuwen CM, Crezee J, Oei AL, et al. (2016). 3D radiobiological evaluation of combined radiotherapy and hyperthermia treatments. Int J Hyperthermia. [Epub ahead of print]. doi: 10.1080/02656736.2016.1241431.
- Dewhirst MW, Lee C-T, Ashcraft KA. (2016). The future of biology in driving the field of hyperthermia. Int J Hyperthermia 32:4–13.
- van Rhoon GC. (2016). Is CEM43 still a relevant thermal dose parameter for hyperthermia treatment monitoring? Int J Hyperthermia 32:50–62.
- Issels R, Kampmann E, Kanaar R, Lindner LH. (2016). Hallmarks of hyperthermia in driving the future of clinical hyperthermia as targeted therapy: translation into clinical application. Int J Hyperthermia 32:89–95.
- Horsman MR. (2016). Realistic biological approaches for improving thermoradiotherapy. Int J Hyperthermia 32:14–22.
- Franken NAP, Oei AL, Kok HP, et al. (2013). Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review). Int J Oncol 42:1501–15.
- Torres-Roca J. (2012). A molecular assay of tumour radiosensitivity: a roadmap towards biology-based personalised radiation therapy. Per Med 9:547–57.
- Myerson RJ, Roti Roti JL, Moros EG, et al. (2004). Modelling heat-induced radiosensitization: clinical implications. Int J Hyperthermia 20:201–12.
- Sapareto SA, Dewey WC. (1982). Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 10:787–800.